Beylerli, Ozal,
Beilerli, Aferin,
Shumadalova, Alina,
Wang, Xiaoxiong,
Yang, Mingchun,
Sun, Hanran,
Teng, Lei (2022) in glioblastoma models by modulating
signaling pathways involved in angiogenesis, apoptosis, chemoresistance
Изменения иммунной системы в патогенезе нейрофиброматоза 1-го типа that block programmed cell death ligand 1 (PD-L1). Activation of MEK
signaling pathways in NF1 leads to PD-L1
Mingazheva, E.T.,
Prokofyeva, D.S.,
Valova, Ya.V.,
Andreeva, E.A.,
Nurgalieva, A.Kh.,
Valiev, R.R.,
Ekomasova, N.V.,
Faishanova, R.R.,
Romanova, A.R.,
Khusnutdinova, E.K. (2022) cell
signaling pathways such as repair, apoptosis, cell cycle
regulation, cell proliferation, migration
Timasheva, Y,
Nasibullin, TR,
Tuktarova, IA,
Erdman, VV,
Galiullin, TR,
Zaplakhova, OV,
Bakhtiiarova, KZ (2022) populations due to admixture and different linkage disequilibrium patterns obscuring true association
signalsIvanova, E.,
Gilyazova, I.,
Pavlov, V.,
Izmailov, A.,
Gimalova, G.,
Karunas, A.,
Prokopenko, I.,
Khusnutdinova, E. (2022) RCC) is a complex disorder that involves numerous biological
pathways, one of the most important of which